Skip to main content
. 2022 May 1;42(3):306–313. doi: 10.3343/alm.2022.42.3.306

Table 2.

Transfusion-related adverse reactions confirmed by the national recipient-triggered traceback system

Year HIV HCV HBV Malaria Others Total
1987–1996 10* 0 0 0 - 10
1997 0 0 1 3 - 4
1998 0 0 0 4 - 4
1999 0 0 4 0 - 4
2000 0 4 2 2 - 8
2001 0 6 6 1 - 13
2002 4 4 0 0 - 8
2003 2 0 1 0 - 3
2004 0 1 0 0 - 1
2005 0 0 0 0 - 0
2006–2013 0 3 1 3 6 13
2014 0 0 0 0 0 0
2015 0 0 0 0 2 2
2016 0 0 0 0 1 1
2017 0 0 0 0 3 3
2018 0 0 0 0 1 1
2019 0 0 0 0 1 1
2020 0 0 0 0 0 0
Total 16 18 15 13 14 76

*HIV confirmed in patients through transfusion: 1987, one case; 1988, one case; 1989, three cases; 1991’, two cases; 1992, two cases; 1993, 1 case; transfusion-related acute lung injury (five cases), acute hemolytic transfusion reaction (four cases), sepsis (bacterial contamination in platelets, three cases), anaphylaxis (one case), suspected hepatitis A virus infection (one case).

Abbreviations: HIV, human immunodeficiency virus; HCV, hepatitis C virus; HBV, hepatitis B virus.